Evidence map›Paper›PMID 37497300›Full record

ArticleFrontiers in pediatrics2023

Impact of the omicron phase on a highly advanced medical facility in Japan.

Hirokazu Yamagishi, Daisuke Tamura, Jun Aoyagi, Shun Suzuki, Yoshitaka Mizobe, Keizo Wakae, Takanori Yamagata, Toshihiro Tajima, Hitoshi Osaka

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hirokazu Yamagishi *Department of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Daisuke Tamura *Department of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Jun AoyagiDepartment of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Shun SuzukiDepartment of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Yoshitaka MizobeDepartment of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Keizo WakaeDepartment of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Takanori Yamagata *Department of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Toshihiro Tajima *Department of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Hitoshi OsakaDepartment of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan.
Jichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Eight waves of the coronavirus disease 2019 (COVID-19) epidemic have been observed in Japan. This retrospective study was conducted to clarify the clinical characteristics of pediatric COVID-19 patients. Methods: We studied 121 patients admitted to the Jichi Children's Medical Center Tochigi between April 2020 and March 2023. Incidence of pediatric COVID-19 in Tochigi Prefecture was used to examine hospitalization and severe illness rates. Results: The mean age of the patients was 3 years and 8 months. One hundred and eleven patients (91.7%) were hospitalized after January 2022 (after the 6th wave), when the Omicron strain became endemic in Japan. Convulsions occurred in 30 patients (24.8%), all of whom were admitted after the 6th wave. Twenty-three of the 30 patients had no underlying disease. Eleven patients (9.1%) were diagnosed with acute encephalopathy. One patient died due to hemorrhagic shock and encephalopathy syndrome and two had sequelae after the 6th wave. The patient who died due to encephalopathy had hypercytokinemia. In the Tochigi Prefecture, the number of pediatric COVID-19 patients increased after the 6th wave, but the hospitalization rate declined. The rate of severe illness did not change before the end of 5th and after the 6th wave. Conclusion: Although the rate of severe illness in patients with pediatric COVID-19 did not increase after the 6th wave, some patients had complicated critical illnesses. Systemic inflammatory reaction was considered to have been associated with the severe encephalopathy.

Indexed as

coronavirus disease 2019febrile seizurepediatricsevere illness ratethe hospitalization rate

Identifiers

PMID37497300
PMCPMC10366354
OpenAlexW4383877972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.